The allogeneic T and B cell response is strongly dependent on complement components C3 and C4

Transplantation

Volumn 72, Issue 7, 2001, Pages 1310-1318

  Marsh, James E ^a   Farmer, Christopher K T ^a   Jurcevic, Stipo ^a   Wang, Yi ^b   Carroll, Michael C ^c   Sacks, Steven H ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b ALEXION PHARMACEUTICALS   (United States)

^c CENTER FOR BLOOD RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; IMMUNOGLOBULIN G;

ALLOIMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE ACTIVATION; COMPLEMENT ACTIVATION; CONTROLLED STUDY; IMMUNOSTIMULATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN GRAFT; T LYMPHOCYTE ACTIVATION;

EID: 0035886199     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200110150-00022     Document Type: Article

References (39)

1. Anti-HLA antibodies after solid organ transplantation
2. Role of complement in induction of the allergic response
3. Immune response of a patient with deficiency of the fourth component of complement and systemic lupus erythematosus
4. Structural differences between the two human complement C4 isotypes affect the humoral immune response
5. Role of C3 in humoral immunity: Defective antibody production in C3-deficient dogs
6. Impaired humoral immune response in complement C3-deficient guinea pigs: Absence of secondary antibody response
7. Influence of genetically inherited complement deficiencies on humoral immune response in guinea pigs
8. T cell-dependent immune response in C1q-deficient mice: Defective interferon gamma production by antigen-specific T cells
9. Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity
10. Regulation of the B cell response to T-dependent antigens by classical pathway complement
11. Disruption of the Cr2 locus results in a reduction in B-la cells and in an impaired B cell response to T-dependent antigen
12. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2
13. Evidence for an important interaction between a complement-derived CD21 ligand on follicular dendritic cells and CD21 on B cells in the initiation of IgG responses
14. Dependence of germinal center B cells on expression of CD21/CD35 for survival
15. Antibody response to a T-dependent antigen requires B cell expression of complement receptors
16. Complement dependence of localisation of aggregated IgG in germinal centres
17. C3d of complement as a molecular adjuvant: Bridging innate and acquired immunity
18. Effects of complement inhibition with soluble complement receptor-1 on vascular injury and inflammation during renal allograft rejection in the rat
19. Allograft rejection in C'6 defective rabbits
20. Role of complement in guinea pig skin allograft rejection. 1. Effect of cobra venom C3 inactivator and fumaropimaric acid on rejection
21. The contribution of terminal complement components to acute and hyperacute allograft rejection in the rat
22. Soluble human complement receptor type 1: In vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis
23. Complement contributes to the rejection of complete and class I major histocompatibility complex: Incompatible cardiac allografts
24. Influence of complement on the allospecific antibody response to a primary vascularized organ graft
25. The technique of free skin grafting in mammals
26. Serotyping for homotransplantation. 18. Refinement of microdroplet lymphocyte cytotoxicity test
27. Study of the optimal reaction conditions for assay of the mouse alternative complement pathway
28. Microassay for colorimetric estimation of complement activity in guinea pig, human and mouse serum
29. Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease
30. Generation of a monoclonal antibody to mouse C5 application in an ELISA assay for detection of anti-C5 antibodies
31. Isolation of pure IgG subclasses from mouse alloantiserum and their activity in enhancement and hyperacute rejection of skin allografts
32. Biological activities of immunoglobulins of different classes and subclasses
33. Activation of mouse complement by monoclonal mouse antibodies
34. Complement deficiencies of laboratory animals
35. Amelioration of lupus-like autoimmune disease in NZB/WF1 mice after treatment with a blocking monoclonal antibody specific for complement component C5
36. Approaching the asymptote? Evolution and revolution in immunology
37. Tolerance, danger, and the extended family
38. Complement opsonization is required for presentation of immune complexes by resting peripheral blood B cells
39. Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells